Jazz Pharmaceuticals Revenue 2007-2019 | JAZZ

Jazz Pharmaceuticals annual/quarterly revenue history and growth rate from 2007 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Jazz Pharmaceuticals revenue for the quarter ending September 30, 2019 was $0.538B, a 14.56% increase year-over-year.
  • Jazz Pharmaceuticals revenue for the twelve months ending September 30, 2019 was $2.056B, a 11.11% increase year-over-year.
  • Jazz Pharmaceuticals annual revenue for 2018 was $1.891B, a 16.82% increase from 2017.
  • Jazz Pharmaceuticals annual revenue for 2017 was $1.619B, a 8.79% increase from 2016.
  • Jazz Pharmaceuticals annual revenue for 2016 was $1.488B, a 12.32% increase from 2015.
Jazz Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $1,891
2017 $1,619
2016 $1,488
2015 $1,325
2014 $1,173
2013 $872
2012 $586
2011 $272
2010 $174
2009 $128
2008 $68
2007 $65
2006 $45
2005 $21
Jazz Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q3 2019 $538
Q2 2019 $534
Q1 2019 $508
Q4 2018 $476
Q3 2018 $469
Q2 2018 $500
Q1 2018 $445
Q4 2017 $436
Q3 2017 $412
Q2 2017 $394
Q1 2017 $376
Q4 2016 $397
Q3 2016 $374
Q2 2016 $381
Q1 2016 $336
Q4 2015 $341
Q3 2015 $341
Q2 2015 $334
Q1 2015 $309
Q4 2014 $328
Q3 2014 $307
Q2 2014 $291
Q1 2014 $247
Q4 2013 $236
Q3 2013 $232
Q2 2013 $208
Q1 2013 $196
Q4 2012 $184
Q3 2012 $176
Q2 2012 $124
Q1 2012 $103
Q4 2011 $84
Q3 2011 $73
Q2 2011 $65
Q1 2011 $51
Q4 2010 $53
Q3 2010 $45
Q2 2010 $40
Q1 2010 $35
Q4 2009 $38
Q3 2009 $31
Q2 2009 $37
Q1 2009 $22
Q4 2008 $20
Q3 2008 $18
Q2 2008 $16
Q1 2008 $15
Q4 2007 $15
Q3 2007 $21
Q2 2007 $14
Q1 2007 $14
Q4 2006
Q3 2006 $11
Q2 2006 $11
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.486B $1.891B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $61.158B 9.66
Zoetis (ZTS) United States $55.822B 33.39
Astellas Pharma (ALPMY) Japan $32.413B 15.44
Eisai (ESALY) Japan $19.472B 37.55
Merck (MKGAF) Germany $15.591B 21.27
Grifols, S.A (GRFS) Spain $14.693B 18.75
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.259B 484.35
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.028B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.015B 16.23
Sage Therapeutics (SAGE) United States $7.312B 0.00
Catalent (CTLT) United States $7.236B 29.44
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.267B 18.93
Arrowhead Pharmaceuticals (ARWR) United States $4.293B 98.42
United Therapeutics (UTHR) United States $3.930B 0.00
Nektar Therapeutics (NKTR) United States $3.579B 0.00
Evotec AG (EVTCY) Germany $3.212B 52.56
FibroGen (FGEN) United States $3.091B 91.18
Taro Pharmaceutical Industries (TARO) Israel $2.934B 10.72
PTC Therapeutics (PTCT) United States $2.574B 0.00
Portola Pharmaceuticals (PTLA) United States $2.154B 0.00
Tilray (TLRY) Canada $2.106B 0.00
Xencor (XNCR) United States $1.972B 59.94
Zogenix (ZGNX) United States $1.963B 0.00
Corcept Therapeutics (CORT) United States $1.841B 22.38
Pacira Pharmaceuticals (PCRX) United States $1.788B 52.89
Ironwood Pharmaceuticals (IRWD) United States $1.780B 56.75
Heron Therapeutics (HRTX) United States $1.655B 0.00
USANA Health Sciences (USNA) United States $1.610B 17.18
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.212B 19.99
Radius Health (RDUS) United States $1.161B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.977B 0.00
Karyopharm Therapeutics (KPTI) United States $0.969B 0.00
ArQule (ARQL) United States $0.953B 0.00
Endo (ENDP) Ireland $0.938B 1.72
Spectrum Pharmaceuticals (SPPI) United States $0.915B 0.00
Aerie Pharmaceuticals (AERI) United States $0.875B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.808B 5.51
TherapeuticsMD (TXMD) United States $0.740B 0.00
Organogenesis Holdings (ORGO) United States $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.642B 0.00
Flexion Therapeutics (FLXN) United States $0.609B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
ChemoCentryx (CCXI) United States $0.559B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.506B 61.38
ImmunoGen (IMGN) United States $0.482B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.472B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.458B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.454B 0.00
Dermira (DERM) United States $0.441B 0.00
Siga Technologies (SIGA) United States $0.412B 9.41
Akebia Therapeutics (AKBA) United States $0.396B 0.00
Indivior (INVVY) United States $0.390B 1.41
DURECT (DRRX) United States $0.385B 0.00
OptiNose (OPTN) United States $0.383B 0.00
Recro Pharma (REPH) United States $0.383B 0.00
Ardelyx (ARDX) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.380B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.374B 16.14
Innate Pharma SA (IPHYF) France $0.372B 0.00
Lannett Co Inc (LCI) United States $0.362B 4.22
Harpoon Therapeutics (HARP) United States $0.324B 0.00
Molecular Templates (MTEM) United States $0.323B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.282B 0.00
GlycoMimetics (GLYC) United States $0.258B 0.00
Rafael Holdings (RFL) United States $0.244B 0.00
Xeris Pharmaceuticals (XERS) United States $0.221B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.208B 0.00
KalVista Pharmaceuticals (KALV) United States $0.200B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.198B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.187B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 31.23
MARKER THERAPEUTICS, INC (MRKR) United States $0.179B 0.00
Concert Pharmaceuticals (CNCE) United States $0.176B 0.00
Calithera Biosciences (CALA) United States $0.167B 0.00
Jounce Therapeutics (JNCE) United States $0.164B 2.19
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
CV Sciences (CVSI) United States $0.152B 0.00
Aquestive Therapeutics (AQST) United States $0.144B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.142B 0.00
CannTrust Holdings (CTST) Canada $0.139B 0.00
MEI Pharma (MEIP) United States $0.138B 0.00
Redhill Biopharma (RDHL) Israel $0.134B 0.00
IMV INC (IMV) Canada $0.131B 0.00
Ocular Therapeutix (OCUL) United States $0.121B 0.00
Cardiome Pharma (CORV) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 25.77
Neos Therapeutics (NEOS) United States $0.079B 0.00
Majesco Entertainment (PTE) United States $0.078B 0.00
MediWound (MDWD) Israel $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.073B 0.00
Generex Biotechnology (GNBT) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.063B 0.00
Natural Alternatives (NAII) United States $0.063B 9.55
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.059B 0.00
Medicure (MCUJF) Canada $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.048B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Nivalis Therapeutics (ALPN) United States $0.045B 0.00
Capnia (SLNO) United States $0.045B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
India Globalization Capital (IGC) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
Mast Therapeutics (SVRA) United States $0.032B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Melinta Therapeutics (MLNT) United States $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
IsoRay (ISR) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 17.17
Regulus Therapeutics (RGLS) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00